OncLive INV-1120 Proves Tolerable in Advanced Solid Tumors, Moves to Expansion in Combination With Pembrolizumab - 1 month Treatment with INV-1120 was well tolerated and demonstrated preliminary signals of stable disease as a single agent in patients with advanced solid... 1608131117609099268 OncLive.com INV-1120 Proves Tolerable in Advanced Solid Tumors, Moves to Expansion in Combination With Pembrolizumab @sitcancer #SITC2022 #SITC22 https://t.co/7nwda8RDiC - view on twitter More coverage: #sitc2022 #sitc22 See more from Share this article × facebook twitter email https://mashupmd.com/inv-1120-proves-tolerable-in-advanced-solid-tumors-moves-to-expansion-in-combination-with-pembrolizumab/ Copy Link
Treatment with INV-1120 was well tolerated and demonstrated preliminary signals of stable disease as a single agent in patients with advanced solid...
INV-1120 Proves Tolerable in Advanced Solid Tumors, Moves to Expansion in Combination With Pembrolizumab @sitcancer #SITC2022 #SITC22 https://t.co/7nwda8RDiC - view on twitter